Selbyville, Delaware, Aug. 13, 2020 (GLOBE NEWSWIRE) -- According to MarketStudyReport LLC, Global molecular diagnostics (MDx) point of care market is anticipated to grow with a CAGR of 13% during 2020-2025. The growth can be credited to rising prevalence of infectious diseases in emerging economies and under-developed countries along with improving healthcare infrastructure and shifting patient preference for home care. Further, favorable government policies are contributing to the market growth.
Global molecular diagnostics (MDx) point of care market, as per the report, is classified into segments based on end-user landscape, test-location, technology spectrum, product type, application scope, and regional terrain. The report documents the driving factors for each segment along with their market share and growth rate during 2020-2025.
On the downside, stringent and time-consuming approval procedures and inefficient arrangement with test results obtained from laboratories are expected to restrain the growth of worldwide molecular diagnostics (MDx) point of care market to some extent.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2767171/
Product terrain:
With respect to product type, the market is classified into software, services, and assays. Among these, the assays segment is expected to hold the largest share in global molecular diagnostics point of care market during 2020-2025, owing to their extensive utilization in specialty clinics, hospital critical care units, and other healthcare services delivery centers.
Elaborating market segmentations:
Based on end-user spectrum, global molecular diagnostics (MDx) point of care market is segmented into homecare, hospitals, decentralized labs, assisted living healthcare facilities, and others. With regards to the test-location, the industry is divided into POC (point-of-care) and OTC (over-the-counter).
Speaking of technology scope, the market is bifurcated into digital PCR, isothermal nucleic acid amplification technology (INAAT), real time PCR, polymerase chain reaction (PCR), and others. While as per application terrain, the industry is classified into hematology, endocrinology, infectious diseases, prenatal testing, oncology, and others.
Regional landscape:
As per industry experts, North America molecular diagnostics (MDx) point of care market held largest revenue share in 2019 and is expected to grow constantly during the forecast period. Whereas, Asia Pacific market is projected to register a y-o-y growth rate of 15.89% during 2020-2025.
Competitive scrutiny:
The report claims that in 2019, Abbott Laboratories (US) partnered with Sanofi (France) to integrate insulin delivery and glucose sensing technologies. Meanwhile, in the same year, Roche Diagnostics, a company based in Switzerland introduced its VENTANA PD-L1 (SP142), that can detect triple-negative breast cancer (TNBC) patients eligible for TECENTRIQ (atezolizumab) treatment.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Global Molecular Diagnostics (MDx) Point of Care Market Application Analysis (Revenue, USD Million, 2015-2025)
- Oncology
- Hematology
- Infectious Diseases
- Endocrinology
- Prenatal Testing
- Others
Global Molecular Diagnostics (MDx) Point of Care Market Technology Analysis (Revenue, USD Million, 2015-2025)
- Real Time PCR
- PCR (Polymerase Chain Reaction)
- Digital PCR
- INAAT (Isothermal Nucleic Acid Amplification Technology)
- Others
Global Molecular Diagnostics (MDx) Point of Care Market Product Analysis (Revenue, USD Million, 2015-2025)
- Software
- Services
- Assays
Global Molecular Diagnostics (MDx) Point of Care Market Test-Location Analysis (Revenue, USD Million, 2015-2025)
- OTC (Over-the-counter)
- POC (Point-of-care)
Global Molecular Diagnostics (MDx) Point of Care Market End-User Analysis (Revenue, USD Million, 2015-2025)
- Hospitals
- Decentralized Labs
- Assisted Living Healthcare Facilities
- Homecare
- Others
Global Molecular Diagnostics (MDx) Point of Care Market Regional Analysis (Revenue, USD Million, 2015-2025)
North America
- Canada
- U.S.
- Mexico
Europe
- Italy
- France
- Germany
- UK
- Spain
- Rest of Europe
Asia Pacific
- Japan
- India
- Australia
- South Korea
- China
- Rest of APAC
Middle East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America
- Argentina
- Brazil
- Rest of South America
Global Molecular Diagnostics (MDx) Point of Care Market Competitive Analysis (Revenue, USD Million, 2015-2025)
- Abbott Laboratories
- Siemens Healthineers
- Mesa Biotech Inc.
- F. Hoffmann-La Roche AG
- Hologic Inc.
- QIAGEN N.V
- DxNA LLC
- Luminex Corporation
- Roche Diagnostics
- Johnson & Johnson
- Danaher Corporation
- EKF Diagnostics
- Quidel Corporation
- Becton Dickinson & Company
- Trinity Biotech
Table of Content:
- Executive Summary
- Start-up Ecosystem
- Expert Verbatim- Interview Excerpts of 10 industry experts
- Global Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
- North America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
- South America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
- Europe Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
- Asia-Pacific Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
- Middle East and Africa Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
- Global Molecular Diagnostics (MDx) Point-of-Care Dynamics
- Global Molecular Diagnostics (MDx) Point-of-Care Region Wise Regulations, Product Standards
- Global Molecular Diagnostics (MDx) Point-of-Care Hotspots & Opportunities
- Competition Outlook
Related Report:
Molecular Diagnostics Market Size, Regional Outlook, Application Potential, Trends, Competitive Market Share & Forecast, 2020 – 2026
Molecular Diagnostics Market size to grow at 9% CAGR from 2020 to 2026, as per new research report. The molecular diagnostics is a collective term for techniques used to analyse biological markers involved in a wide range of human ailments. Molecular diagnostic tests are the elementary part of a successful health care system. Molecular diagnostic tests provide critical information that helps the healthcare providers and patients to make the right medical decisions for better outcome of a medical procedure.
Latin America molecular diagnostics market is expected to reach a valuation of more than $1 billion by 2026, which is attributable to the rising awareness about cost-effective molecular diagnostics options among general population.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.